EP2101697A4
(en )
2010-10-20
Treatment of meibomian glands
PT2954932T
(en )
2018-12-12
Therapeutic use of diaminophenothiazines
IL250314A0
(en )
2017-03-30
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
AP2860A
(en )
2014-02-28
Carbazole compounds and therapeutic uses of the compounds
NO2016023I1
(en )
2016-12-14
Methods of treatment using ammonia-scavenging drugs
SI2467372T1
(en )
2016-09-30
Treatment of bdnf-related disorders using laquinimod
IL211835A0
(en )
2011-05-31
Therapeutic uses of inhibitors of rtp801
GB0921075D0
(en )
2010-01-13
Novel combination of the therapeutic agents
GB0908193D0
(en )
2009-06-24
Treatment of disease state
HRP20130041T8
(en )
2013-03-31
Therapeutic agents
GB0906159D0
(en )
2009-05-20
Drug combination for the treatment of proteostatic diseases
HRP20181877T1
(en )
2019-01-11
Methods of treatment using ammonia-scavenging drugs
EP2231129A4
(en )
2013-01-30
Therapeutic regimens for the treatment of immunoinflammatory disorders
EP2164494A4
(en )
2010-06-02
Methods of treatment
IL213606A0
(en )
2011-07-31
1-amino-alkylcyclohexane derivatives for the treatment of inflamatory skin diseases
GB0723100D0
(en )
2008-01-02
Treatment of HFnEF
EP2203174A4
(en )
2010-09-29
Therapeutic regimens for the treatment of immunoinflammatory disorders
GB0712956D0
(en )
2007-08-15
Therapeutic uses of cannabinoids
SI2330892T1
(en )
2017-05-31
Methods of treatment using ammonia-scavenging drugs
GB0716834D0
(en )
2007-10-10
New formulation for treatment of skin disorders
GB0700969D0
(en )
2007-02-28
Methods of treatment
GB0819543D0
(en )
2008-12-03
Treatment of proteostatic disease
GB0817859D0
(en )
2008-11-05
Treatment of proteostatic disease
GB0616122D0
(en )
2006-09-20
Formulation for treatment of skin disorders
GB0625602D0
(en )
2007-01-31
Treatment of sialorrhoea